Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| GMP-L07H24GB01 | Human | CytoPak™ GMP Human IL-7 Protein |  |
||
| IL7-H5116 | Human | Human IL-7 Protein (E. coli), premium grade |  |
|
|
| RES-A055 | Human | resDetect™ Human Interleukin-7 (IL-7) ELISA Kit (Residue Testing) | |||
| IL7-Y84 | Mouse | Mouse IL-7 Antibody, Mouse IgG1 (4C9F12) |
|
|
|
| IL7-M52H3 | Mouse | Mouse IL-7 Protein, His Tag |  |
|
|
| GMP-L07H24 | Human | GMP Human IL-7 Protein |  |
|
|
| IL7-H5253 | Human | Human IL-7 Protein, Fc Tag (MALS verified) |  |
|
|
| IL7-H4219 | Human | Human IL-7 Protein, premium grade |  |
|
Human IL-7 Protein (E. coli), premium grade (Cat. No. IL7-H5116) stimulates proliferation of PHA-P-activated human peripheral blood mononuclear cell (PBMC). The specific activity of Human IL-7 Protein (E. coli), premium grade > 1.00ⅹ10^8 IU/mg, which is calibrated against human IL-7 WHO International Standard (NIBSC code: 90/530) (QC tested).
GMP Human IL-7 Protein (Cat. No. GMP-L07H24) stimulates proliferation of PHA-P-activated human peripheral blood mononuclear cell (PBMC). The specific activity of GMP Human IL-7 is > 1.00×10^8 IU/mg, which is calibrated against human IL-7 WHO International Standard (NIBSC code: 90/530) (QC tested).
Mouse IL-7 Antibody, Mouse IgG1 (4C9F12) (Cat. No. IL7-Y84) immobilized on CM5 Chip can bind Human IL-7, premium grade (Cat. No. IL7-H4219) with an affinity constant of 2.83 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Anti-GPC3 chimeric antigen receptor T cell therapy (Hunan Zhaotai Yongren Biotech/Guangdong Zhaotai Invivo Biomedicine) | Phase 1 Clinical | Hunan Zhaotai Yongren Biotech Co Ltd, Guangdong Zhaotai Invivo Biomedicine Co Ltd | Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung | Details | |
| ADP-TILIL7 | ADP-TILIL7 | Phase 1 Clinical | Adaptimmune Therapeutics Plc | Melanoma | Details |
| GSK-3888130-B | GSK3888130B; GSK-3888130; GSK-3888130-B | Phase 1 Clinical | Glaxosmithkline Plc | Multiple Sclerosis | Details |
| BNT-152 | BNT-152 | Phase 1 Clinical | Biontech Se | Solid tumours | Details |
This web search service is supported by Google Inc.
A-Z
